ACTIVE

Apotheek Legrand

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

241 k €

+23.2% YoY

Gross margin

348,5 k €

+13.5% YoY

Equity

359,2 k €

+0.1% YoY

Workforce

1,3 ETP

-23.5% YoY

What does Apotheek Legrand do?

Apotheek Legrand is a Private limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Zonnebeke. It employs on average 1,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0446.469.818

Incorporation

23/01/1992

Legal form

Private limited company

Registered office

Molenstraat 1A
8980 Zonnebeke · FlandreSee on map

Contributed capital

61 973,38 €

Latest accounts

31/12/2025

Average workforce

1,3 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (2)

313
3130

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	348,5 k €	+13.5%	307 k €	+30.4%	235,5 k €	+214%	75 k €	-52.2%	156,7 k €	+44.0%	108,8 k €	-36.5%	171,4 k €	-35.1%	263,9 k €	-19.4%	327,3 k €	+7.8%	303,6 k €	-10.4%	338,7 k €	+30.0%	260,7 k €	+0.8%	258,6 k €	+10.3%	234,3 k €	+10.3%	212,4 k €	+11.5%	190,5 k €	-9.7%	211 k €	+6.6%	197,9 k €	+7.3%	184,4 k €	+9.5%	168,3 k €
EBITDA	276,3 k €	+24.7%	221,6 k €	+34.7%	164,5 k €	+786%	-24 k €	-1322%	2 k €	+106%	-35,1 k €	-396%	11,9 k €	-88.3%	101,3 k €	-45.9%	187,2 k €	+18.1%	158,5 k €	-20.1%	198,4 k €	+45.6%	136,3 k €	-1.2%	137,9 k €	+16.4%	118,5 k €	+11.7%	106,1 k €	+5.2%	100,8 k €	-14.7%	118,2 k €	+11.6%	105,9 k €	+5.8%	100,1 k €	-8.4%	109,2 k €
Operating result	244,3 k €	+23.8%	197,3 k €	+24.4%	158,6 k €	+625%	-30,2 k €	-626%	-4,2 k €	+90.3%	-42,8 k €	-1613%	2,8 k €	-96.9%	91,3 k €	-40.7%	154 k €	+21.9%	126,3 k €	-23.0%	164,1 k €	+68.0%	97,6 k €	-3.0%	100,7 k €	+20.7%	83,4 k €	+26.7%	65,8 k €	+53.0%	43 k €	-24.4%	56,9 k €	+44.4%	39,4 k €	+25.9%	31,3 k €	-39.5%	51,7 k €
Net result	241 k €	+23.2%	195,7 k €	+22.3%	160 k €	+624%	-30,5 k €	-682%	-3,9 k €	+90.8%	-42,5 k €	-3050%	1,4 k €	-97.7%	63,4 k €	-34.8%	97,3 k €	+17.1%	83,1 k €	-19.8%	103,6 k €	-10.2%	115,4 k €	+0.1%	115,3 k €	+7.3%	107,5 k €	+21.6%	88,4 k €	+26.2%	70 k €	-9.2%	77,1 k €	+44.6%	53,3 k €	+16.3%	45,8 k €	-17.3%	55,5 k €
Balance sheet
Equity	359,2 k €	+0.1%	358,9 k €	+3.1%	348,3 k €	-28.7%	488,3 k €	-5.9%	518,8 k €	-0.7%	522,7 k €	-7.5%	565,2 k €	+0.3%	563,7 k €	-47.8%	1,1 M €	+9.9%	983 k €	+9.2%	900 k €	+13.0%	796,4 k €	+689%	100,9 k €	-87.8%	830 k €	+14.2%	726,5 k €	+13.1%	642,1 k €	+11.5%	576,1 k €	+14.5%	503 k €	+10.8%	453,8 k €	+10.2%	412 k €
Total assets	669,6 k €	-5.5%	708,7 k €	+41.0%	502,6 k €	-7.5%	543,6 k €	-23.8%	713,5 k €	+2.3%	697,2 k €	+2.6%	679,8 k €	-12.6%	777,7 k €	-44.2%	1,4 M €	+10.2%	1,3 M €	+4.1%	1,2 M €	-3.9%	1,3 M €	+1.2%	1,2 M €	+13.9%	1,1 M €	+11.4%	985,2 k €	+9.5%	899,4 k €	+9.7%	820,2 k €	+12.9%	726,4 k €	+5.6%	688 k €	+4.3%	659,8 k €
Cash	156,3 k €	-7.7%	169,3 k €	+33.7%	126,6 k €	+35.7%	93,3 k €	-56.8%	215,9 k €	+36.0%	158,8 k €	+12.4%	141,3 k €	+16.0%	121,8 k €	-48.5%	236,8 k €	+58.5%	149,4 k €	+83.9%	81,2 k €	+23.7%	65,7 k €	-41.0%	111,3 k €	+137%	47 k €	+38.1%	34 k €	+71.6%	19,8 k €	-29.3%	28 k €	+129%	12,2 k €	-53.8%	26,4 k €	+0.9%	26,2 k €
Debts	310,4 k €	-11.2%	349,7 k €	+127%	154,4 k €	+183%	54,5 k €	-72.0%	194,5 k €	+11.5%	174,5 k €	+52.3%	114,6 k €	-46.4%	213,9 k €	-28.1%	297,5 k €	+12.5%	264,4 k €	-10.3%	294,7 k €	-35.0%	453,6 k €	-60.1%	1,1 M €	+346%	254,6 k €	-0.8%	256,7 k €	+5.7%	243 k €	+5.0%	231,3 k €	+9.5%	211,2 k €	-7.4%	228 k €	-6.3%	243,3 k €
Other
Workforce	1,3 ETP	-23.5%	1,7 ETP	+13.3%	1,5 ETP	-25.0%	2,0 ETP	-35.5%	3,1 ETP	+3.3%	3,0 ETP	+7.1%	2,8 ETP	+12.0%	2,5 ETP	+25.0%	2,0 ETP	-9.1%	2,2 ETP	+4.8%	2,1 ETP	+5.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	+25.0%	1,6 ETP	0.0%	1,6 ETP	-20.0%	2,0 ETP	+42.9%	1,4 ETP	+40.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 20 ended

Active mandates

Pharma Legrand

Director · 0771.765.553

Represented by Legrand Lore

Active

Ended mandates

Pharma Legrand

Director · since 01 janvier 2023 · 0771.765.553

Represented by Lore LEGRAND

Ended

Pharma Legrand

Director · since 31 décembre 2022 · 0771.765.553

Represented by Legrand LORE

Ended

CLF INVEST

Director · since 30 juin 2018 · 0849.355.160

Represented by Florence Clarebout

Ended

CLF INVEST

Manager · since 30 juin 2018 · 0849.355.160

Represented by Florence Clarebout

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	14/07/2025	30/08/2024	17/07/2023	31/08/2022	30/08/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	02/07/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	14/07/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	17/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	31/08/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	30/08/2021	Dutch	PDF
Abridged model	31/12/2019	31/08/2020	10/09/2020	Dutch	PDF
Abridged model	31/12/2018	31/07/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	21/06/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	29/05/2017	Dutch	PDF
Abridged model	31/12/2015	27/05/2016	18/08/2016	Dutch	PDF
Abridged model	31/12/2014	29/05/2015	26/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/05/2014	25/07/2014	Dutch	PDF
Abridged model	31/12/2012	31/05/2013	18/07/2013	Dutch	PDF
Abridged model	31/12/2011	25/05/2012	27/08/2012	Dutch	PDF
Abridged model	31/12/2010	27/05/2011	04/08/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	24/06/2010	Dutch	PDF
Abridged model	31/12/2008	29/05/2009	14/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	30/07/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	30/05/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 20 ended

Active mandates

Pharma Legrand

Director · 0771.765.553

Represented by Legrand Lore

Active

Ended mandates

Pharma Legrand

Director · since 01 janvier 2023 · 0771.765.553

Represented by Lore LEGRAND

Ended

Pharma Legrand

Director · since 31 décembre 2022 · 0771.765.553

Represented by Legrand LORE

Ended

CLF INVEST

Director · since 30 juin 2018 · 0849.355.160

Represented by Florence Clarebout

Ended

CLF INVEST

Manager · since 30 juin 2018 · 0849.355.160

Represented by Florence Clarebout

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other06/03/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ALGEMENE VERGADERING
PDF
Mandates18/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/09/2018
BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/08/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares23/04/2018
KAPITAAL - AANDELEN
PDF
Mandates11/02/2014
DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
PDF
Mandates16/09/2009
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/06/2004
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025241 k €↑
2024
Annual accounts 2024195,7 k €↑
2023
Annual accounts 2023160 k €↑
2022
Annual accounts 2022-30,5 k €↓
2022
Name changeAPOTHEEK LEGRAND
2021
Annual accounts 2021-3,9 k €↑
2020
Annual accounts 2020-42,5 k €↓
2019
Annual accounts 20191,4 k €↓
2018
Annual accounts 201863,4 k €↓
2018
Name changeAPOTHEEK Passendale
2017
Annual accounts 201797,3 k €↑
2016
Annual accounts 201683,1 k €↓
2015
Annual accounts 2015103,6 k €↓
2014
Annual accounts 2014115,4 k €↑
2013
Annual accounts 2013115,3 k €↑
2012
Annual accounts 2012107,5 k €↑
2011
Annual accounts 201188,4 k €↑
2010
Annual accounts 201070 k €↓
2009
Annual accounts 200977,1 k €↑
2008
Annual accounts 200853,3 k €↑
2007
Annual accounts 200745,8 k €↓
2006
Annual accounts 200655,5 k €
2006
Name changeApotheek Schaubroeck V.
23/01/1992
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Apotheek Legrand

Overview

What does Apotheek Legrand do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline